Using Cryopreserved Human Liver Cells to Study Trichloroethylene Metabolism
Author Information
Author(s): Bronley-DeLancey Apryl, McMillan David C., McMillan JoEllyn M., Jollow David J., Mohr Lawrence C., Hoel David G.
Primary Institution: Medical University of South Carolina
Hypothesis
Polymorphisms in chloral hydrate metabolism may yield subpopulations with increased risk of liver tumors after trichloroethylene exposure.
Conclusion
Cryopreserved human hepatocytes can be effectively used to study the metabolism of chloral hydrate and its implications for trichloroethylene cancer risk assessment.
Supporting Evidence
- Chloral hydrate is a major metabolite of trichloroethylene formed in the liver.
- Large interindividual variation in the Vmax values for both TCOH and TCA formation was observed.
- The disposition of chloral hydrate into its competing pathways was relatively constant despite individual variations.
- Genetic polymorphisms in ADH and ALDH may influence the metabolism of chloral hydrate.
Takeaway
Scientists used special liver cells from humans to see how a chemical called chloral hydrate is broken down, which helps understand cancer risks from another chemical, trichloroethylene.
Methodology
The study involved examining the metabolism of chloral hydrate using cryopreserved human hepatocytes and correlating the results with ADH and ALDH genotypes.
Potential Biases
Potential bias due to the limited representation of certain genotypes in the sample.
Limitations
The small sample size limits the ability to draw definitive conclusions about the correlation between genotype and metabolic activity.
Participant Demographics
The study included 13 human hepatocyte samples from various donors with differing ages, sexes, and races.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website